Application Note: Gyrolab® immunoassays to support vaccine development and production
Bioanalysis during vaccine development presents many challenges in assay complexity, sample matrices, analyte types, and demands on workflow efficiency. Immunoassays are used to characterize vaccine titer, purity, and potency, as well as their immunogenic response in both animals and humans.
This Application Note presents examples of how Gyrolab systems have increased the performance of immunoassays in vaccine development, immunogenicity and affinity of antigen-antibody interactions in early development, to the measurement of antigen titer and HCP impurities in bioprocessing.
Please complete this form to download the case study PDF, "Gyrolab Immunoassays to Support Vaccine Development and Production."